PubMed:32232433 / 1630-1822 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-OGER-BB

    {"project":"LitCovid-OGER-BB","denotations":[{"id":"T34","span":{"begin":60,"end":66},"obj":"UBERON:0000970"},{"id":"T35","span":{"begin":124,"end":136},"obj":"UBERON:0001811"},{"id":"T36","span":{"begin":158,"end":166},"obj":"UBERON:0002532"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"A total of 12 of 38 patients (31.6%; 95% CI, 17.5-48.7) had ocular manifestations consistent with conjunctivitis, including conjunctival hyperemia, chemosis, epiphora, or increased secretions."}

    LitCovid-sentences-v1

    {"project":"LitCovid-sentences-v1","denotations":[{"id":"TextSentencer_T15","span":{"begin":0,"end":192},"obj":"Sentence"}],"text":"A total of 12 of 38 patients (31.6%; 95% CI, 17.5-48.7) had ocular manifestations consistent with conjunctivitis, including conjunctival hyperemia, chemosis, epiphora, or increased secretions."}

    LitCovid-TimeML

    {"project":"LitCovid-TimeML","denotations":[{"id":"tok306","span":{"begin":0,"end":1},"obj":"DT"},{"id":"tok307","span":{"begin":2,"end":7},"obj":"NN"},{"id":"tok308","span":{"begin":8,"end":10},"obj":"IN"},{"id":"tok309","span":{"begin":11,"end":13},"obj":"CD"},{"id":"tok310","span":{"begin":14,"end":16},"obj":"IN"},{"id":"tok311","span":{"begin":17,"end":19},"obj":"CD"},{"id":"tok312","span":{"begin":20,"end":28},"obj":"NNS"},{"id":"tok313","span":{"begin":29,"end":30},"obj":"("},{"id":"tok314","span":{"begin":30,"end":32},"obj":"CD"},{"id":"tok315","span":{"begin":32,"end":33},"obj":"."},{"id":"tok316","span":{"begin":33,"end":34},"obj":"CD"},{"id":"tok317","span":{"begin":34,"end":35},"obj":"NN"},{"id":"tok318","span":{"begin":35,"end":36},"obj":":"},{"id":"tok319","span":{"begin":37,"end":39},"obj":"CD"},{"id":"tok320","span":{"begin":39,"end":40},"obj":"NN"},{"id":"tok321","span":{"begin":41,"end":43},"obj":"NNP"},{"id":"tok322","span":{"begin":43,"end":44},"obj":","},{"id":"tok323","span":{"begin":45,"end":47},"obj":"CD"},{"id":"tok324","span":{"begin":47,"end":48},"obj":"."},{"id":"tok325","span":{"begin":48,"end":49},"obj":"CD"},{"id":"tok326","span":{"begin":49,"end":50},"obj":":"},{"id":"tok327","span":{"begin":50,"end":52},"obj":"CD"},{"id":"tok328","span":{"begin":52,"end":53},"obj":"."},{"id":"tok329","span":{"begin":53,"end":54},"obj":"CD"},{"id":"tok330","span":{"begin":54,"end":55},"obj":")"},{"id":"tok331","span":{"begin":56,"end":59},"obj":"VBD"},{"id":"tok332","span":{"begin":60,"end":66},"obj":"NN"},{"id":"tok333","span":{"begin":67,"end":81},"obj":"NNS"},{"id":"tok334","span":{"begin":82,"end":92},"obj":"JJ"},{"id":"tok335","span":{"begin":93,"end":97},"obj":"IN"},{"id":"tok336","span":{"begin":98,"end":112},"obj":"NNS"},{"id":"tok337","span":{"begin":112,"end":113},"obj":","},{"id":"tok338","span":{"begin":114,"end":123},"obj":"VBG"},{"id":"tok339","span":{"begin":124,"end":136},"obj":"NN"},{"id":"tok340","span":{"begin":137,"end":146},"obj":"NN"},{"id":"tok341","span":{"begin":146,"end":147},"obj":","},{"id":"tok342","span":{"begin":148,"end":156},"obj":"NNS"},{"id":"tok343","span":{"begin":156,"end":157},"obj":","},{"id":"tok344","span":{"begin":158,"end":166},"obj":"NN"},{"id":"tok345","span":{"begin":166,"end":167},"obj":","},{"id":"tok346","span":{"begin":168,"end":170},"obj":"CC"},{"id":"tok347","span":{"begin":171,"end":180},"obj":"VBD"},{"id":"tok348","span":{"begin":181,"end":191},"obj":"NNS"},{"id":"tok349","span":{"begin":191,"end":192},"obj":"."},{"id":"lookup36","span":{"begin":34,"end":35},"obj":"percent"},{"id":"lookup37","span":{"begin":39,"end":40},"obj":"percent"},{"id":"event17","span":{"begin":171,"end":180},"obj":"OCCURRENCE"}],"text":"A total of 12 of 38 patients (31.6%; 95% CI, 17.5-48.7) had ocular manifestations consistent with conjunctivitis, including conjunctival hyperemia, chemosis, epiphora, or increased secretions."}

    LitCovid-PD-HP-v1

    {"project":"LitCovid-PD-HP-v1","denotations":[{"id":"T1","span":{"begin":98,"end":112},"obj":"Phenotype"},{"id":"T2","span":{"begin":124,"end":146},"obj":"Phenotype"},{"id":"T3","span":{"begin":148,"end":156},"obj":"Phenotype"},{"id":"T4","span":{"begin":158,"end":166},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0000509"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0030953"},{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0012375"},{"id":"A4","pred":"hp_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/HP_0009926"}],"text":"A total of 12 of 38 patients (31.6%; 95% CI, 17.5-48.7) had ocular manifestations consistent with conjunctivitis, including conjunctival hyperemia, chemosis, epiphora, or increased secretions."}

    LitCovid-PD-MONDO-v1

    {"project":"LitCovid-PD-MONDO-v1","denotations":[{"id":"T16","span":{"begin":98,"end":112},"obj":"Disease"},{"id":"T17","span":{"begin":158,"end":166},"obj":"Disease"}],"attributes":[{"id":"A16","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0003799"},{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0001793"}],"text":"A total of 12 of 38 patients (31.6%; 95% CI, 17.5-48.7) had ocular manifestations consistent with conjunctivitis, including conjunctival hyperemia, chemosis, epiphora, or increased secretions."}